Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen's egg chorioallantoic membrane and excised bovine cornea models

International Journal of Pharmaceutics

Volumn 432, Issue 1-2, 2012, Pages 1-10

  Abdelkader, Hamdy ^a,c   Ismail, Sayed ^b   Hussein, Amal ^c   Wu, Zimei ^a   Al Kassas, Raida ^a   Alany, Raid G ^a,d  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b Assiut University   (Egypt)

^c Minia University   (Egypt)

^d KINGSTON UNIVERSITY   (United Kingdom)

Author keywords

Bovine cornea; Naltrexone hydrochloride; Niosomes; Ocular delivery; Opioid growth factor

Indexed keywords

CHOLIC ACID; FLUORESCEIN; NALTREXONE; NIOSOME;

ANIMAL TISSUE; ARTICLE; CHORIOALLANTOIS; CONTROLLED STUDY; CORNEA EROSION; CORNEA OPACITY; CORNEA PERMEABILITY; CORNEA THICKNESS; DRUG FORMULATION; DRUG TOLERABILITY; HISTOLOGY; KERATOPATHY; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, OPHTHALMIC; ANIMALS; CATTLE; CHICKENS; CHORIOALLANTOIC MEMBRANE; CONJUNCTIVA; CORNEA; CORNEAL OPACITY; FEMALE; IRRITANTS; LIPOSOMES; NALTREXONE; NARCOTIC ANTAGONISTS;

EID: 84861591784     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.04.063     Document Type: Article

References (40)

1. G. Abdelbary, and N. El-gendy Niosome-encapsulated gentamicin for ophthalmic controlled delivery AAPS PharmSciTech 9 2008 740 747
2. H. Abdelkader, S. Ismail, H. Kamal, and R.G. Alany Design and evaluation of controlled release niosomes and discomes for naltrexone hydrochloride ocular delivery J. Pharm. Sci. 100 2011 1833 1846
3. H. Abdelkader, D. Patel, C. McGhee, and R.G. Alany New therapeutic approaches in treatment of diabetic keratopathy Clin. Exp. Opthalmol. 39 2011 259 270
4. H. Abdelkader, Z. Wu, R. Al-Kassas, J.E. Brown, and R. Alany Preformulation characteristics of the opioid growth factor antagonist-naltrexone hydrochloride: stability and lipophilicity studies J. Drug Deliv. Sci. Tech. 21 2011 157 163
5. R.G. Alany, T. Rades, J. Nicoll, I.G. Tucker, and N.M. Davies W/O microemulsions for ocular delivery: evaluation of ocular irritation and precorneal retention J. Control. Release 111 2006 145 152
6. D. Anderson, and T. Russell D. Anderson, T. Russell, The Status of Alternative Methods in Toxicology 1995 The Royal Society of Chemistry Cambridge, UK 21 33
7. R. Auerbach, L. Kubai, D. Knighton, and J. Folkman A simple procedure for the long-term cultivation of chicken embryos Dev. Biol. 41 1974 391 394
8. J. Avalos, A. Jacobs, and J.K. Wilkin Toxicity testing for ocular drug products K. Green, Advances in Ocular Toxicology 1997 Plenum New York 261 268
9. P.K. Basu Toxic effects of drugs on the corneal epithelium: a review Cutan. Ocul. Toxicol. 2 1984
10. P.K. Basu, M. Avaria, and R. Jankie Effect of hydrocortisone on the mobilization of leucocytes on the corneal wounds Br. J. Ophthalmol. 65 1981 694 698
11. L.H. Bruner Ocular irritation J.M. Frazier, In Vitro Toxicity Testing: Applications to Safety Evaluation 1992 CRC Press New York 149 190
12. P. Budai, J. Lehel, J. Tavaszi, and E. Kormos HET-CAM test for determining the possible eye irritancy of pesticides Acta Veter. Hung. 58 2010 369 377
13. J.D. Buehler Cholesterol R.C. Rowe, P.L. Sheskey, P.L. Weller, Handbook of Pharmaceutical Excipients 4th ed. 2003 Pharmaceutical Press London 155 157
14. N. Cuellar, J. Merrill, M. Clear, G. Mun, and J.W. Harbell The application of Benchmarks for the evaluation of the potential ocular irritancy of aerosol fragrances The Toxicologist 66 2002 243 244
15. D.R. Curren, M.G. Evans, H.A. Raabe, R.R. Ruppalt, and J.W. Harbell Correlation of histopathology, opacity and permeability of bovine corneas exposed in vitro to known ocular irritants Vet. Pathol. 37 2000 557
16. R.D. Curren, and J.W. Harbell In vitro alternatives for ocular irritation Environ. Health Perspect. 106 1998 485 492
17. C.S. Foster, J.H. Lass, K. Moran-Wallace, and R. Giovanoni Ocular toxicity of topical antifungal agents Arch. Ophthalmol. 99 1981 1081 1084
18. P. Furrer, J.M. Mayer, B. Plazonnet, and R. Gurny Ocular tolerance of absorption enhancers in ophthalmic preparations AAPS PharmSci. 4 2002
19. A.S. Guinedi, N.D. Mortada, S. Mansour, and R.M. Hathout Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide Int. J. Pharm. 306 2005 71 82
20. Harbell, J.W., Mun, G., Curren, R.D., 2006. Application of histological evaluation to enhance the bovine opacity and permeability (BCOP) assay. Paper presented at the 45th Annual Society of Toxicology Meeting, San Diego, CA, USA.
21. J.W. Harbell, H.A. Raabe, M.G. Evans, and R.D. Curren Histopathology associated with opacity and permeability changes in bovine corneas in vitro The Toxicologist 48 1999 336 337
22. B. Hughes, V. Feiz, S.B. Flynn, and M.C. Brodsky Reversible amantadine-induced corneal edema in an adolescent Cornea 23 2004 823 824
23. Y. Kinouchi, Y. Takeichi, and N. Yata A novel method for the preclinical assessment of rectal irritation J. Pharm. Pharmacol. 48 1996 310 315
24. J.C. Lang, R.E. Roehrs, D.P. Rodeheaver, P.J. Missel, R. Jani, and M.A. Chowhan Design and evaluation of ophthalmic pharmaceutical products G.S. Banker, C.T. Rhodes, Modern Pharmaceutics 2002 Marcel Dekker New York 626 717
25. M.J. Lawrence Sorbitan esters (sorbitan fatty acid esters) R.C. Rowe, P.L. Sheskey, P.L. Weller, Handbook of Pharmaceutical Excipients 4th ed. 2003 Pharmaceutical Press London 591 595
26. R.S. Lawrence, M.H. Groom, D.M. Ackroyd, and W.E. Parish The chorioallantoic membrane in irritation testing Food Chem. Toxicol. 24 1986 497 502
27. J.P. Li, R.C. Tripathi, and B.J. Tripathi Drug-induced ocular disorders Drug Saf. 31 2008 127 141
28. N.P. Luepke Hen's egg chorioallantoic membrane test for irritation potential Food Chem. Toxicol. 23 1985 287 291
29. T. Nishida Cornea J.H. Krachmer, M.J. Mannis, E.J. Holland, Cornea: Fundamentals, Diagnosis and Management vol. 1 2005 Elsevier Philadelphia 3 21
30. R.R. Pfister, and N. Burstein The effects of ophthalmic drugs, vehicles, preservatives on corneal epithelium: a scanning electron microscope study Invest. Ophthalmol. Vis. Sci. 15 1976 246 259
31. B.G. Short Safety evaluation of ocular drug delivery formulations: techniques and practical considerations Toxicologic Pathol. 36 2008 49 62
32. P.J. Weterings, and Y.H. Vanerp Validation of the Becam assay: an eye irritancy screening test A.M. Goldberg, Alternative Methods in Toxicology vol. 5 1987 Mary Ann Liebert, Inc. New York 515 521
33. I.S. Zagon, J.B. Jenkins, J.W. Sassani, J.D. Wylie, T.B. Ruth, J.L. Fry, C.M. Lang, and P.J. McLaughlin Naltrexone, an opioid antagonist, facilitates reepithelialization of the cornea in diabetic rat Diabetes 51 2002 3055 3062
34. I.S. Zagon, M.A. Klocek, J.W. Sassani, D.T. Mauger, and J.P. McLaughlin Corneal safety of topically applied naltrexone J. Ocul. Pharmacol. Ther. 22 2006 377 387
35. I.S. Zagon, M.S. Klocek, J.W. Sassani, and P.J. McLaughlin Dry eye reversal and corneal sensation restoration with topical naltrexone in diabetes mellitus Arch. Ophthalmol. 127 2009 1468 1473
36. I.S. Zagon, J.W. Sassani, and P.J. McLaughlin Re-epithelialization of the rabbit cornea is regulated by opioid growth factor Brain Res. 803 1998 61 68
37. I.S. Zagon, J.W. Sassani, and P.J. McLaughlin Re-epithelialization of the rat cornea is accelerated by blockade of opioid receptors Brain Res. 798 1998 254 260
38. I.S. Zagon, J.W. Sassani, and P.J. McLaughlin Reepithelialization of the human cornea is regulated by endogenous opioids Invest. Ophthalmol. Vis. Sci. 41 2000 73 81
39. I.S. Zagon, J.W. Sassani, R.L. Myers, and P.J. McLaughlin Naltrexone accelerates healing without compromise of adhesion complexes in normal and diabetic corneal epithelium Br. Res. Bull. 72 2007 18 24
40. I.S. Zagon, M.F. Verderame, and P.J. McLaughlin The biology of the opioid growth factor receptor(OGFr) Br. Res. Rev. 38 2002 351 376